Atlas Trials

Variations of Immune Infiltrate and Cell Plasticity Markers in Treated Metastatic Melanoma Patients

Clinical trial NCT05029791 · RECRUITING

Trial details

NCT number
NCT05029791
Sponsor
Hospices Civils de Lyon
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Melanoma
Start date
2022-08-18
Primary completion
2031-11-18
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.